Rivaroxaban Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk

Clinical trial NCT04753372 · COMPLETED

Trial details

NCT number: NCT04753372
Sponsor: Maatschap Cardiologie Zwolle
Status: COMPLETED
Study type: OBSERVATIONAL

Coronary Artery Disease (CAD)Peripheral Arterial Disease (PAD)

Start date: 2020-12-21
Primary completion: 2023-09-13
Enrollment: 645

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.